i2o Therapeutics, based in Boston, MA, is a cutting-edge biotechnology company focused on developing next-generation biologics and peptides for improved patient outcomes. With a mission to transform patient care, i2o Therapeutics is dedicated to creating innovative delivery platforms and medicines that have the potential to revolutionize the healthcare industry.
Committed to advancing the field of biotechnology, i2o Therapeutics is at the forefront of developing disruptive technologies that aim to address unmet medical needs. Through their research and development efforts, i2o Therapeutics is poised to make significant contributions to the future of healthcare and improve the lives of patients worldwide.
Generated from the website